Cargando…
Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA
Genetic sequencing of malignancies has become increasingly important to uncover therapeutic targets and capture the tumor's dynamic changes to drug sensitivity and resistance through genomic evolution. In lung cancers, the current standard of tissue biopsy at the time of diagnosis and progressi...
Autores principales: | Offin, Michael, Chabon, Jacob J., Razavi, Pedram, Isbell, James M., Rudin, Charles M., Diehn, Maximilian, Li, Bob T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368362/ https://www.ncbi.nlm.nih.gov/pubmed/28392802 http://dx.doi.org/10.1155/2017/4517834 |
Ejemplares similares
-
Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013) -
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019) -
Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
por: Sivapalan, Lavanya, et al.
Publicado: (2023) -
A mathematical model of ctDNA shedding predicts tumor detection size
por: Avanzini, Stefano, et al.
Publicado: (2020) -
Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)